企業プロフィール
Tiziana Life Sciences 株価・ニュース・カタリスト
- ティッカー:
- TLSA
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United Kingdom and trades in the U
株価パフォーマンス
1.15 USD (+1.32%)
終値
最終更新: 2026年8月17日
173M USD
時価総額
株価変動の要因
As of Aug 17, 2026, TLSA closed up 1.32% at $1.15. No new same-company headline was identified in the current news window.
企業概要
事業概要
Tiziana Life Sciences is a biotechnology company focused on immune modulation and respiratory or inflammatory disease applications. Its story centers on using biologic or cellular approaches to influence difficult disease pathways.
所在地とセクター分類
Tiziana is headquartered in the United Kingdom and trades in the U.S. market. It sits in small-cap biotechnology.
ビジネスモデルの特徴
The company depends on translational progress, clinical validation, and strategic focus across a narrow pipeline. Investors usually watch early data and whether the platform can sharpen its therapeutic thesis.
バイオ業界での位置付け
Tiziana occupies a niche immune-modulation position within biotech. It is a catalyst-driven small-cap name where scientific proof matters more than commercial scale.
今後のカタリスト
- Tiziana’s catalysts are foralumab and the neuro / autoimmune programs, with any update that clarifies whether the platform can still progress. The market will want a cleaner clinical path.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。